BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34854525)

  • 1. Characterization of bone homeostasis in individuals affected by cardio-facio-cutaneous syndrome.
    Leoni C; Viscogliosi G; Onesimo R; Bisanti C; Massese M; Giorgio V; Corbo F; Tedesco M; Acampora A; Cipolla C; Dell'Atti C; Flex E; Gervasoni J; Primiano A; Rigante D; Tartaglia M; Zampino G
    Am J Med Genet A; 2022 Feb; 188(2):414-421. PubMed ID: 34854525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cardio-facio-cutaneous syndrome case with tight Achilles tendons.
    Hazan F; Aykut A; Hizarcioglu M; Tavli V; Onay H; Ozkinay F
    Genet Couns; 2012; 23(2):305-11. PubMed ID: 22876591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardio-facio-cutaneous syndrome and gastrointestinal defects: report on a newborn with 19p13.3 deletion including the MAP 2 K2 gene.
    Serra G; Felice S; Antona V; Di Pace MR; Giuffrè M; Piro E; Corsello G
    Ital J Pediatr; 2022 May; 48(1):65. PubMed ID: 35509048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is diagnosing cardio-facio-cutaneous (CFC) syndrome still a challenge? Delineation of the phenotype in 15 Polish patients with proven mutations, including novel mutations in the BRAF1 gene.
    Ciara E; Pelc M; Jurkiewicz D; Kugaudo M; Gieruszczak-Białek D; Skórka A; Posmyk R; Jakubiuk-Tomaszuk A; Cieślikowska A; Chrzanowska KH; Jezela-Stanek A; Krajewska-Walasek M
    Eur J Med Genet; 2015 Jan; 58(1):14-20. PubMed ID: 25463315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardio-facio-cutaneous syndrome-associated pathogenic MAP2K1 variants activate autophagy.
    Chen J; Che L; Xu C; Zhao S; Yang J; Li M; Li G; Shen Y
    Gene; 2020 Apr; 733():144369. PubMed ID: 31972311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroblastoma-like tumor of the skull in a patient with cardio-facio-cutaneous syndrome.
    Fasciano D; Wei S; Li R; Siegal GP
    Pathol Res Pract; 2018 Sep; 214(9):1510-1513. PubMed ID: 30100356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased bone mineral density in Costello syndrome.
    Leoni C; Stevenson DA; Martini L; De Sanctis R; Mascolo G; Pantaleoni F; De Santis S; La Torraca I; Persichilli S; Caradonna P; Tartaglia M; Zampino G
    Mol Genet Metab; 2014 Jan; 111(1):41-5. PubMed ID: 24246682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAP2K2 mutation as a cause of cardio-facio-cutaneous syndrome in an infant with a severe and fatal course of the disease.
    Gos M; Smigiel R; Kaczan T; Landowska A; Abramowicz A; Sasiadek M; Bal J
    Am J Med Genet A; 2018 Jul; 176(7):1670-1674. PubMed ID: 29799162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antenatal diagnosis of cardio-facio-cutaneous syndrome: Prenatal characteristics and contribution of fetal facial dysmorphic signs in utero. About a case and review of literature.
    Biard JM; Steenhaut P; Bernard P; Race V; Sznajer Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():232-241. PubMed ID: 31336229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical analysis of a child with cardio-facio-cutaneous syndrome due to a de novo variant of MAP2K1 gene].
    Cao H; Tong G; Huang R; Zhou T; Zhang W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Oct; 39(10):1129-1134. PubMed ID: 36184098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Musculo-skeletal phenotype of Costello syndrome and cardio-facio-cutaneous syndrome: insights on the functional assessment status.
    Leoni C; Romeo DM; Pelliccioni M; Di Già M; Onesimo R; Giorgio V; Flex E; Tedesco M; Tartaglia M; Rigante D; Valassina A; Zampino G
    Orphanet J Rare Dis; 2021 Jan; 16(1):43. PubMed ID: 33482860
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Aoidi R; Houde N; Landry-Truchon K; Holter M; Jacquet K; Charron L; Krishnaswami SR; Yu BD; Rauen KA; Bisson N; Newbern J; Charron J
    Dis Model Mech; 2018 Mar; 11(3):. PubMed ID: 29590634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway.
    Allanson JE
    Am J Med Genet A; 2016 Oct; 170(10):2570-7. PubMed ID: 27155212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial cardio-facio-cutaneous syndrome: Vertical transmission of the BRAF p.G464R pathogenic variant and review of the literature.
    Rauen KA; Maeda Y; Egense A; Tidyman WE
    Am J Med Genet A; 2021 Feb; 185(2):469-475. PubMed ID: 33274568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrous dysplasia in cardio-facio-cutaneous syndrome: A case report and review of literature.
    Dong X; Png NCY; Fortier MV; Lim JY; Wong KPL; Choo JTL; Tan EC; Jamuar SS
    Am J Med Genet A; 2022 Sep; 188(9):2732-2737. PubMed ID: 35801299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Craniofacial and dental development in cardio-facio-cutaneous syndrome: the importance of Ras signaling homeostasis.
    Goodwin AF; Oberoi S; Landan M; Charles C; Groth J; Martinez A; Fairley C; Weiss LA; Tidyman WE; Klein OD; Rauen KA
    Clin Genet; 2013 Jun; 83(6):539-44. PubMed ID: 22946697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of a de novo MAP2K1 gene variant in an affected patient with Cardio-facio-cutaneous syndrome].
    Wang Q; Chen P; Peng Q; Liu J; Huang Y; Tang Z; Liu Y; Yuan H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 May; 37(5):567-569. PubMed ID: 32335888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of MEK1 and MEK2 gene mutations in cardio-facio-cutaneous syndrome and genotype-phenotype correlations.
    Dentici ML; Sarkozy A; Pantaleoni F; Carta C; Lepri F; Ferese R; Cordeddu V; Martinelli S; Briuglia S; Digilio MC; Zampino G; Tartaglia M; Dallapiccola B
    Eur J Hum Genet; 2009 Jun; 17(6):733-40. PubMed ID: 19156172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An acute encephalopathy with reduced diffusion in BRAF-associated cardio-facio-cutaneous syndrome.
    Okuzono S; Fukai R; Noda M; Miyake N; Lee S; Kaku N; Sanefuji M; Akamine S; Kanno S; Ishizaki Y; Torisu H; Kira R; Matsumoto N; Sakai Y; Ohga S
    Brain Dev; 2019 Apr; 41(4):378-381. PubMed ID: 30414707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of MAP2K2/MEK2: a novel mechanism for a RASopathy?
    Nowaczyk MJ; Thompson BA; Zeesman S; Moog U; Sanchez-Lara PA; Magoulas PL; Falk RE; Hoover-Fong JE; Batista DA; Amudhavalli SM; White SM; Graham GE; Rauen KA
    Clin Genet; 2014 Feb; 85(2):138-46. PubMed ID: 23379592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.